A new report by the Economic Alliance of Greater Baltimore and BioHealth Innovation Inc. says Maryland must pick up the pace on entrepreneurship to be the national leader in biohealth
Ahead of the Johns Hopkins Social Innovation Lab’s Impact and Innovation Forum on April 21, we’re profiling the entrepreneurs that are part of the current cohort.
Here’s a look at three startups focused on building health solutions in Baltimore:
Register to attend the Celebration of Innovation and Partnerships at the University of Maryland
When: May 9, 2016 Time: 4:00-6:00 pm Where: Orem Hall, Riggs Alumni Center, University of Maryland
These new inventions will be honored at a special Celebration of Innovation and Partnerships event on May 9 as part of the University of Maryland’s “30 Days of EnTERPreneurship.” Each year, UMD honors exceptional inventions that have the potential to make an important impact on science, society, and the free market. The Invention of the Year award nominees come from three categories: Physical Sciences, Life Sciences, and Information Sciences. One invention from each category is selected to win the Invention of the Year Award.
The German conglomerate that invented aspirin over a century ago wants to take over much more of your medicine cabinet. Bayer AG is boosting its presence and brand in the U.S., the world’s biggest medicine market. Bayer is increasing everything from marketing and research operations in the U.S. to the number of its nonprescription medicines in pharmacies and grocery stores.
Since World War II, the U.S. has been an innovation superpower. In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. Other nations may challenge in one field or another, but no one can match its depth and breadth.
Partnerships with private corporations can be valuable for universities looking to speed up the process of translating academic research to commercial products, services and companies.
USM Chancellor Caret sees big opportunity in private industry research – Washington Business Journal
Dedicated rules for conducting research with private companies could be a new revenue source for USM and could avoid another chocolate milk debacle.
The NIH is the premier biomedical research center for the world. Its 27 Institutes and Centers employ approximately 18,000 employees doing a vast array of jobs, all supporting efforts for a healthy nation. For information on the NIH mission, goals, and Institutes and Centers, visit NIH Overview
This position is located in the Technology Transfer Center (TTC) of the National Cancer Institute (NCI), National Institutes of Health (NIH). The Technology Transfer Center of the National Cancer Institute is seeking exceptional, dynamic candidates for the Invention Development and Marketing Supervisor. The Supervisor will mentor, empower and lead the newly formed Invention Development and Marketing Unit, and drive the strategy to accelerate and increase the volume of NCI inventions matched with partners who can commercialize federal inventions to improve public health. The ideal candidate will have an understanding of research and development in a federal setting, but bring the mindset and energy of an entrepreneur to lead the team, please visit http://ttc.nci.nih.gov/.
MedImmune has introduced the phrase “BioHealth Capital Region” to brand Greater Washington’s biotech and life sciences sectors and hopes the name will grow organically.
Gov. Larry Hogan called the state’s life sciences industry the “backbone of Maryland’s economy” and said the state must do more to drive new business here.
Hogan spoke at the close of the first day of the BioHealth Capital Region Forum, a two-day event taking place at MedImmune’s Rockville headquarters Monday and Tuesday.